← Eichor
Study identifier: NCT06950905 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Contemplative Practice for Well-being and Self-Deconstruction in Women

Condition: Mental Health · Self Concept · Body Dissatisfaction  ·  Sponsor: Hospital Miguel Servet

PhaseNA
Planned participants122
Who can joinFemale, 30 Years to 60 Years
Healthy volunteersNo

About this study

This randomized controlled trial aims to evaluate the effectiveness of a contemplative practice called Feeding Your Demons (FYD), based on a secular adaptation of Tibetan Buddhism, in improving psychological well-being, body image, body acceptance, compassion, and self-deconstruction in adult women. Participants will be randomly assigned to either FYD or an active control group practicing mindfulness meditation. Psychological variables will be assessed before and after the intervention, and at a six-month follow-up. Additionally, a qualitative exploration will be conducted through interviews with a subgroup of participants.

This description comes directly from the study's public registry record.

Talk to the study team

Javier Garcia Campayo  ·  976 50 65 78  ·  investigaprimaria@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Department of Psychiatry. Miguel Servet University HospitalZaragoza, Zaragoza, SpainNot Yet Recruiting
University of ZaragozaZaragoza, Zaragoza, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06950905